However, many people without diabetes can still obtain this prescription drug through less stringent channels and use it for weight loss
Then came the second generation, think the next iPhone upgrade
FDA Approval Timeline As of mid-2025, Retatrutide is: Still under investigation in phase 3 clinical trials Expected to complete primary trials by late 2025 Anticipated to receive FDA approval in 2026 Until then, it is available only for research purposes , and should not be used outside of controlled clinical settings without professional supervision
Glucagon receptor activation: the game changer for energy expenditure This is what sets retatrutide apart from every other weight loss medication on the market
For condition updates and practical education, browse our Type 2 Diabetes articles
If you start the Eden weight loss program with semaglutide, treatment is typically given as a once-weekly injection, depending on what your provider prescribes